Africa’s First HIV Cure Trial Offers Hope 20% of Patients Remain Drug-Free After 1.5 Years
In a first-ever milestone, Africa’s initial HIV cure trial has yielded historic findings: 20% of patients have remained off antiretroviral therapy (ART) for over a year and a half and have the virus under control. The trial, conducted in Durban, South Africa, tested a new immunotherapy approach that seeks to eliminate latent HIV reservoirs and ...
